Shwartzman reaction after human renal homotransplantation.

PubWeight™: 4.05‹?› | Rank: Top 1%

🔗 View Article (PMC 2765870)

Published in N Engl J Med on March 21, 1968


T E Starzl, R A Lerner, F J Dixon, C G Groth, L Brettschneider, P I Terasaki

Articles citing this

Liver transplantation (1). N Engl J Med (1989) 4.53

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc (1970) 2.63

Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery (1970) 2.38

Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33

The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation (1992) 1.83

Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant (1989) 1.74

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

A trial with heterologous antilymphocyte globulin in man. Transplant Proc (1969) 1.51

A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50

The effect of FK-506 on hyperacute rejection in presensitized rats. Transplant Proc (1987) 1.49

Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol (1988) 1.45

Neutrophil function in selected surgical disorders. Ann Surg (1968) 1.40

Clinical heterotransplantation of the liver. Transplant Proc (1970) 1.35

Presensitization and kidney transplant failures. Postgrad Med J (1971) 1.33

Endotoxemia and human liver transplantation. Transplant Proc (1989) 1.28

Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. Ann Surg (1987) 1.19

Body temperature changes during organ transplantation. Anesth Analg (1971) 1.17

The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc (1987) 1.13

Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements. Transplant Proc (1971) 1.08

Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. An experimental study. Am J Pathol (1972) 1.05

The nature of experimental second-set kidney transplant rejection. 1. The role of coagulation in hyperacute (second-set) renal allotransplant rejection in dogs. Br J Exp Pathol (1970) 1.01

Renal Transplantation in the Presence of a Positive Cytotoxic Antibody. Transplant Proc (1988) 0.99

Prospects of clinical xenotransplantation. Transplant Proc (1994) 0.98

Clinical patterns of renal allograft rejection. Ann Surg (1971) 0.98

Studies on cellular and humoral immune factors in human renal transplantation. Ann Surg (1971) 0.93

Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate. Surgery (1971) 0.93

Antibodies and human transplant rejection. Ann Surg (1969) 0.92

History of clinical transplantation. World J Surg (2000) 0.91

The nature of experimental second-set kidney transplant rejection. 3. The role of complement. Br J Exp Pathol (1971) 0.90

The pathology of renal homograft rejection. A review. Am J Pathol (1976) 0.89

Modification of xenograft response by selective plasmapheresis. Transplant Proc (1971) 0.88

Hyperacute rejection of the kidney in patients with a negative crossmatch. Transplant Proc (1988) 0.86

Human leukocyte antigen antibodies for monitoring transplant patients. Surg Today (2005) 0.86

Analysis of anesthetic-related morbidity in human recipients of renal homografts. Anesth Analg (1971) 0.86

Allograft outcomes in outbred mice. Am J Transplant (2013) 0.85

Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci (1998) 0.84

The future of transplantation: with particular reference to chimerism and xenotransplantation. Transplant Proc (1997) 0.83

Histologic changes in preserved cadaveric renal transplants. Am J Pathol (1977) 0.82

Patterns of vascular damage in the antibody-mediated rejection of skin xenografts in the mouse. Am J Pathol (1980) 0.81

Human liver xenotransplantation. Xeno (1993) 0.81

The role of complement in the induction of acute antibody-mediated vasculitis of rat skin grafts in the mouse. Am J Pathol (1982) 0.80

Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts. Transplantation (1990) 0.79

Organ transplantation, past and present. Surg Clin North Am (1968) 0.79

Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience. J Transplant (2010) 0.79

Functional aspects of the rejection of transplanted kidneys. Calif Med (1971) 0.78

Progress in disseminated intravascular coagulation. II. Calif Med (1969) 0.78

Clinical xenotransplantation. Xenotransplantation (1994) 0.78

Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. Transplantation (1996) 0.78

Crossmatch testing in kidney transplantation: patterns of practice and associations with rejection and graft survival. Saudi J Kidney Dis Transpl (2009) 0.77

Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment. Transplantation (1973) 0.76

The nature of experimental second-set kidney transplant rejection. 4. The disturbed haemodynamics and the general significance of failure to perfuse the outer cortical glomeruli in acute renal failure. Br J Exp Pathol (1971) 0.76

The development of clinical renal transplantation. Am J Kidney Dis (1990) 0.75

Histocompatibility in organ transplantation. Ann R Coll Surg Engl (1973) 0.75

The first baboon-to-human transplants. Xenotransplantation (1996) 0.75

The leucocyte migration technique as an assay of presensitization to human transplantation antigens. Clin Exp Immunol (1975) 0.75

Acute antibody-mediated rejection of skin grafts without involvement of granulocytes or complement. Am J Pathol (1984) 0.75

Renal transplantation-cadaveric donor. Calif Med (1971) 0.75

The basis of allograft acceptance. Forum (Genova) (1997) 0.75

Articles by these authors

A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66

Nucleotide sequence of Moloney murine leukaemia virus. Nature (1981) 24.82

Evolution of liver transplantation. Hepatology (1982) 19.54

Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol (1988) 13.78

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99

The structure of an antigenic determinant in a protein. Cell (1984) 10.85

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90

Murine models of systemic lupus erythematosus. Adv Immunol (1985) 9.79

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature (1996) 8.99

Immunogenic structure of the influenza virus hemagglutinin. Cell (1982) 8.93

Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91

Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51

Mitotic misregulation and human aging. Science (2000) 8.47

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest (1976) 8.06

Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein. J Biol Chem (1977) 8.03

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88

The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med (1967) 6.81

Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. Proc Natl Acad Sci U S A (1977) 6.80

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A (1991) 6.13

Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med (1969) 6.03

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A (1991) 5.94

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science (1989) 5.73

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50

Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Tapping the immunological repertoire to produce antibodies of predetermined specificity. Nature (1982) 5.11

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80

Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79

Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A (1983) 4.56

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40

Etiopathogenesis of murine SLE. Immunol Rev (1981) 4.39

Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature (1980) 4.35

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differentiation antigens encoded by a multi-gene family. Nature (1977) 4.31

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A (1981) 4.26

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein. Nature (1984) 4.05

Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science (1967) 4.01

Encoded combinatorial chemistry. Proc Natl Acad Sci U S A (1992) 4.00

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83

Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes. Science (1995) 3.82

Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol (1978) 3.78

Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

The pathogenesis of glomerulonephritis. Am J Med (1968) 3.61

Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med (1978) 3.58

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med (1976) 3.51

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49